221 related articles for article (PubMed ID: 25988524)
41. The p90 ribosomal S6 kinase (RSK) is a mediator of smooth muscle contractility.
Artamonov M; Momotani K; Utepbergenov D; Franke A; Khromov A; Derewenda ZS; Somlyo AV
PLoS One; 2013; 8(3):e58703. PubMed ID: 23516539
[TBL] [Abstract][Full Text] [Related]
42. RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer.
Serra V; Eichhorn PJ; García-García C; Ibrahim YH; Prudkin L; Sánchez G; Rodríguez O; Antón P; Parra JL; Marlow S; Scaltriti M; Pérez-Garcia J; Prat A; Arribas J; Hahn WC; Kim SY; Baselga J
J Clin Invest; 2013 Jun; 123(6):2551-63. PubMed ID: 23635776
[TBL] [Abstract][Full Text] [Related]
43. Divergent off-target effects of RSK N-terminal and C-terminal kinase inhibitors in cardiac myocytes.
Stathopoulou K; Schobesberger S; Bork NI; Sprenger JU; Perera RK; Sotoud H; Geertz B; David JP; Christ T; Nikolaev VO; Cuello F
Cell Signal; 2019 Nov; 63():109362. PubMed ID: 31344438
[TBL] [Abstract][Full Text] [Related]
44. Regulation and function of the RSK family of protein kinases.
Romeo Y; Zhang X; Roux PP
Biochem J; 2012 Jan; 441(2):553-69. PubMed ID: 22187936
[TBL] [Abstract][Full Text] [Related]
45. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.
McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Dorfman AL; Longnus S; Pende M; Martin KA; Blenis J; Thomas G; Izumo S
Mol Cell Biol; 2004 Jul; 24(14):6231-40. PubMed ID: 15226426
[TBL] [Abstract][Full Text] [Related]
46. Muscle A-kinase-anchoring protein-β-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D.
Li J; Aponte Paris S; Thakur H; Kapiloff MS; Dodge-Kafka KL
J Biol Chem; 2019 Feb; 294(7):2543-2554. PubMed ID: 30523159
[TBL] [Abstract][Full Text] [Related]
47. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte.
Chan AY; Soltys CL; Young ME; Proud CG; Dyck JR
J Biol Chem; 2004 Jul; 279(31):32771-9. PubMed ID: 15159410
[TBL] [Abstract][Full Text] [Related]
48. MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in mice.
Pereira AH; Clemente CF; Cardoso AC; Theizen TH; Rocco SA; Judice CC; Guido MC; Pascoal VD; Lopes-Cendes I; Souza JR; Franchini KG
PLoS One; 2009 Dec; 4(12):e8472. PubMed ID: 20041152
[TBL] [Abstract][Full Text] [Related]
49. Targeting mAKAPβ expression as a therapeutic approach for ischemic cardiomyopathy.
Martinez EC; Li J; Ataam JA; Tokarski K; Thakur H; Karakikes I; Dodge-Kafka K; Kapiloff MS
Gene Ther; 2023 Aug; 30(7-8):543-551. PubMed ID: 35102273
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling.
Karakikes I; Chaanine AH; Kang S; Mukete BN; Jeong D; Zhang S; Hajjar RJ; Lebeche D
J Am Heart Assoc; 2013 Apr; 2(2):e000078. PubMed ID: 23612897
[TBL] [Abstract][Full Text] [Related]
51. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
[TBL] [Abstract][Full Text] [Related]
52. ERK and RSK regulate distinct steps of a cellular program that induces transition from multicellular epithelium to single cell phenotype.
Čáslavský J; Klímová Z; Vomastek T
Cell Signal; 2013 Dec; 25(12):2743-51. PubMed ID: 24012955
[TBL] [Abstract][Full Text] [Related]
53. Mechanism of sustained activation of ribosomal S6 kinase (RSK) and ERK by kaposi sarcoma-associated herpesvirus ORF45: multiprotein complexes retain active phosphorylated ERK AND RSK and protect them from dephosphorylation.
Kuang E; Wu F; Zhu F
J Biol Chem; 2009 May; 284(20):13958-13968. PubMed ID: 19304659
[TBL] [Abstract][Full Text] [Related]
54. Enhanced JunD/RSK3 signalling due to loss of BRD4/FOXD3/miR-548d-3p axis determines BET inhibition resistance.
Tai F; Gong K; Song K; He Y; Shi J
Nat Commun; 2020 Jan; 11(1):258. PubMed ID: 31937753
[TBL] [Abstract][Full Text] [Related]
55. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
[TBL] [Abstract][Full Text] [Related]
56. MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit.
Willard FS; Crouch MF
Cell Signal; 2001 Sep; 13(9):653-64. PubMed ID: 11495723
[TBL] [Abstract][Full Text] [Related]
57. Complex formation between S100B protein and the p90 ribosomal S6 kinase (RSK) in malignant melanoma is calcium-dependent and inhibits extracellular signal-regulated kinase (ERK)-mediated phosphorylation of RSK.
Hartman KG; Vitolo MI; Pierce AD; Fox JM; Shapiro P; Martin SS; Wilder PT; Weber DJ
J Biol Chem; 2014 May; 289(18):12886-95. PubMed ID: 24627490
[TBL] [Abstract][Full Text] [Related]
58. P90 ribosomal S6 kinase confers cancer cell survival by mediating checkpoint kinase 1 degradation in response to glucose stress.
Ma Y; Cui D; Wang L; Wang Y; Yang F; Pan H; Gong L; Zhang M; Xiong X; Zhao Y
Cancer Sci; 2022 Jan; 113(1):132-144. PubMed ID: 34668620
[TBL] [Abstract][Full Text] [Related]
59. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
[TBL] [Abstract][Full Text] [Related]
60. Role of p90(RSK) in regulating the Crabtree effect: implications for cancer.
Redman EK; Brookes PS; Karcz MK
Biochem Soc Trans; 2013 Feb; 41(1):124-6. PubMed ID: 23356270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
